Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Dec 4, 2025 | EviCore by Evernorth | Octreotide acetate injection (Sandostatin LAR Depot, Sandostatin) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Octreotide Products (Sandostatin, Sandostatin LAR) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Octreotide acetate injection (Sandostatin LAR Depot, Sandostatin) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Ocrelizumab (Ocrevus) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Ocrevus (ocrelizumab) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Ocriplasmin (Jetrea) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Ocrelizumab (Ocrevus) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Ocrelizumab (Ocrevus) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Ocrelizumab (Ocrevus) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Ocrelizumab (Ocrevus) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Nusinersen (Spinraza) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Ocrelizumab (Ocrevus) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Nusinersen (Spinraza) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Nusinersen (Spinraza) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Nusinersen (Spinraza) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Nusinersen (Spinraza) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Nucala (mepolizumab) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Nucala (mepolizumab) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Nulibry (fosdenopterin) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Nusinersen (Spinraza) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Nulibry (fosdenopterin) | Created |
| Dec 4, 2025 | EviCore by Evernorth | NovoSeven RT (coagulation factor VIIa [recombinant]) | Created |
| Dec 4, 2025 | EviCore by Evernorth | New Specialty Drugs | Created |
| Dec 4, 2025 | EviCore by Evernorth | New Specialty Drugs | Created |
| Dec 4, 2025 | EviCore by Evernorth | Natalizumab (Tysarbi) | Created |
| Dec 4, 2025 | EviCore by Evernorth | New Medical Drug Management Policy | Created |
| Dec 4, 2025 | EviCore by Evernorth | New Medical Drug Management Policy | Created |
| Dec 4, 2025 | EviCore by Evernorth | Natalizumab (Tysabri) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Natalizumab (Tysabri) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Natalizumab (Tysabri) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Natalizumab (Tysabri) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Natalizumab (Tysabri) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Natalizumab (Tysabri) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Natalizumab (Tysabri) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Naltrexone (Vivitrol) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Naglazyme (galsulfase) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Myobloc (rimabotulinumtoxinB) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Monoferric (ferric derisomaltose) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Mitoxantrone | Created |
| Dec 4, 2025 | EviCore by Evernorth | Myobloc (rimabotulinumtoxinB) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Mircera (methoxy polyethylene glycol-epoetin beta) Injection | Created |
| Dec 4, 2025 | EviCore by Evernorth | Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) Injection | Created |
| Dec 4, 2025 | EviCore by Evernorth | Mircera (methoxy polyethylene glycol- epoetin beta) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Mircera(methoxy polyethylene glycol- epoetin beta) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) Injection | Created |
| Dec 4, 2025 | EviCore by Evernorth | Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Mepolizumab (Nucala) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Mepolizumab (Nucala) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Mepolizumab (Nucala) | Created |